Literature DB >> 25581303

A new algorithm to reduce inappropriate therapy in the S-ICD system.

Amy J Brisben1, Martin C Burke2, Bradley P Knight3, Stephen J Hahn1, Keith L Herrmann1, Venugopal Allavatam1, Deepa Mahajan1, Rick Sanghera1, Michael R Gold4.   

Abstract

INTRODUCTION: The subcutaneous ICD system (S-ICD) has been shown to be a safe and effective treatment for patients at risk for sudden cardiac death. This device reliably detects ventricular tachyarrhythmias with a low incidence of inappropriate shocks for supraventricular arrhythmias. However, T-wave oversensing (TWOS) is more common with the S-ICD compared with transvenous systems. We developed a novel discrimination algorithm to reduce TWOS without compromising tachyarrhythmia discrimination. METHODS AND
RESULTS: The algorithm was developed using a database of recorded episodes, including 244 appropriate therapies for ventricular arrhythmias and 133 episodes with an inappropriate detection due to TWOS, and using a computer model that simulates the S-ICD system. An independent set of data of 161 TWOS episodes, 137 ventricular and 328 supraventricular episodes, was used to validate the algorithm on actual device hardware. The S-ICD performance with the new algorithm was compared with the S-ICD without the new algorithm. Development results showed a decrease in inappropriate charge due to TWOS by 30.7 ± 18%. All ventricular arrhythmias were appropriately detected and the time to appropriate charge initiation was not increased. System validation showed that the new algorithm avoided an inappropriate charge due to TWOS by 39.8 ± 11.4%. No decrease in ventricular arrhythmia sensitivity and no significant change in supraventricular specificity were observed.
CONCLUSIONS: A new algorithm that uses correlation of the existing complex to previous complexes reduced TWOS episodes by approximately 40%. The algorithm has potential for a clinically meaningful decrease in inappropriate shocks.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  S-ICD; T-wave oversensing; algorithm; inappropriate shocks; subcutaneous implantable cardioverter defibrillator

Mesh:

Year:  2015        PMID: 25581303     DOI: 10.1111/jce.12612

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  27 in total

1.  The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations.

Authors:  Hussam Ali; Pierpaolo Lupo; Riccardo Cappato
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-08

2.  Limitations in S-ICD therapy: reasons for system explantation.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-07-07       Impact factor: 5.460

Review 3.  [Leadless pacemakers and subcutaneously implantable cardioverter defibrillators].

Authors:  C Stellbrink; B Hansky; D Meyer Zu Vilsendorf
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

Review 4.  [Management of inappropriate shocks/T-wave-oversensing in S-ICD®-patients].

Authors:  Robert Larbig; Markus Bettin; Lukas J Motloch; Alicia Fischer; Niklas Bode; Gerrit Frommeyer; Florian Reinke; Andreas Loeher; Lars Eckardt; Julia Köbe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-02-12

5.  Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.

Authors:  Vincent C Thomas; Mark Peterson; Martin McDaniel; Humberto Restrepo; Abraham Rothman; Amit Jain
Journal:  Pediatr Cardiol       Date:  2017-05-22       Impact factor: 1.655

6.  ICD Therapy for Primary Prevention in Hypertrophic Cardiomyopathy.

Authors:  Amar Trivedi; Bradley P Knight
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

7.  Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience.

Authors:  Gerrit Frommeyer; Dirk G Dechering; Sven Zumhagen; Andreas Löher; Julia Köbe; Lars Eckardt; Florian Reinke
Journal:  Clin Res Cardiol       Date:  2015-08-02       Impact factor: 5.460

8.  Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.

Authors:  Marcin Grabowski; Monika Gawałko; Marcin Michalak; Andrzej Cacko; Michał Kowara; Agnieszka Kołodzińska; Łukasz Januszkiewicz; Paweł Balsam; Laura Vitali Serdoz; Joachim Winter; Grzegorz Opolski
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

9.  The subcutaneous implantable cardioverter-defibrillator: A tertiary center experience.

Authors:  Cesar Khazen; Peter Magnusson; Johannes Flandorfer; Christoph Schukro
Journal:  Cardiol J       Date:  2018-05-02       Impact factor: 2.737

10.  A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter-defibrillator.

Authors:  Yuji Ishida; Shingo Sasaki; Yuichi Toyama; Kimitaka Nishizaki; Yoshihiro Shoji; Takahiko Kinjo; Taihei Itoh; Daisuke Horiuchi; Masaomi Kimura; Michael R Gold; Hirofumi Tomita
Journal:  Heart Rhythm O2       Date:  2020-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.